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Abstract: The synthesis and aqueous self-assembly of a new
class of amphiphilic aliphatic polyesters are presented. These
AB block polyesters comprise polycaprolactone (hydrophobe)
and an alternating polyester from succinic acid and an ether-
substituted epoxide (hydrophile). They self-assemble into
biodegradable polymersomes capable of entering cells. Their
degradation products are bioactive, giving rise to differentiated
cellular responses inducing stromal cell proliferation and
macrophage apoptosis. Both effects emerge only when the
copolymers enter cells as polymersomes and their magnitudes
are size dependent.
Aliphatic polyesters can be biocompatible and biodegrad-
able, and as such they are important materials for medical
devices, tissue engineering, and in drug delivery.[1] Three FDA
approved and widely applied hydrophobic polyesters are
poly(e-caprolactone) (PCL), polylactide (PLA), and poly-
(lactic-co-glycolic acid) (PLGA). By copolymerizing them
with hydrophilic blocks it is possible to access amphiphiles
that self-assemble, in water, into micelles or vesicles (also
known as polymersomes).[1c,2] In general, such supramolec-
ular self-assembly is a highly successful example of molecular
bioengineering, providing control over particle size, architec-
ture, surface chemistry, degradation rate, and mechanical
properties.[1c,2a,3]
When designing nanocarriers there are many successful
hydrophobic polymers to choose from, including aliphatic
polyesters, carbonates, and peptides.[4] In terms of hydrophilic
blocks, poly(ethylene glycol) (PEG) is ubiquitous and forms
nanostructures with prolonged blood circulation times, result-
ing in “stealth” delivery.[5] For example, paclitaxel-loaded
PLA-PEG micelles have been used in cancer treatment since
2007 and related PEG-based nanoparticles are in late-stage
clinical trials.[6] Nonetheless, PEG is not biodegradable and its
use can cause renal accumulation and sensitivity.[1b] Polymeric
alternatives to PEG are known but expanding the scope of
new hydrophilic materials remains important.[7] Here, a new
polymer-based nanomedicine concept is presented and it
exploits fully degradable, amphiphilic block polyesters.
Amphiphilic polyesters have long been targeted but are
very difficult to prepare by condensation polymerization
methods. Such block polymers are best synthesized by
controlled polymerizations and the well-known method for
polyesters, lactone ring-opening polymerization (ROP), is
most effective for hydrophobic blocks.[8] It has been used to
make a few hydrophilic polyesters but such processes require
complex monomer syntheses, hydrophile protection/depro-
tection strategies, and may be hampered by low polymer-
izability.[9] Recently, the ring-opening copolymerization
(ROCOP) of epoxides and anhydrides has emerged as
a tolerant, functional-group compatible synthesis, but so far
applications for the resulting alternating polyesters are under-
explored.[10] Here, new amphiphilic block polyesters are
prepared by e-caprolactone (e-CL) ROP, followed by
ROCOP of succinic anhydride (SA) and 2-((2-(2-(2-meth-
oxyethoxy)ethoxy)ethoxy)methyl)oxirane (ME3MO; Fig-
ure 1a; see Figure S2 in the Supporting Information). The
polyesters are deliberately designed to degrade to metabo-
lites.
First, two different PCL macroinitiators were prepared by
e-CL ROP using an organocatalyst, and control of monomer/
catalyst loadings afforded PCL38-OH and PCL54-OH (Table 1;
see Table S1). The PCL samples showed narrow, monomodal
molar mass distributions with masses, evaluated by both SEC
and 1H NMR spectroscopy, in excellent agreement with
theory.
For each sample, the degree of polymerization (PCLn) was
calculated from the 1H NMR integrals for the polymer
methylene signals against the chain end groups (see Fig-
ure S1). The PCL macroinitiators were subsequently used in
the ROCOPof SA andME3MO (Figure 1a; see Figure S2).
[14]
This reaction was catalyzed using a commercial CrIII system
[salenCr(Cl)/PPNCl] and was monitored, by aliquot analysis,
and terminated when succinic acid conversion was greater
than 80%. One drawback is that the cocatalyst (PPNCl)
delivers an alternative initiating group (Cl) which contam-
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inates the block polymer. To overcome the problem, a tenfold
excess of macroinitiator was applied and residual alternating
polymer was removed by repeated precipitations (see the
Supporting Information for details). The purified block
polymers, PCL-b-PE, all show higher Mn values than the
PCL precursors and narrow dispersities (see Figure S3). By
controlling monomer loadings, it was straightforward to
access amphiphiles with hydrophobic weight contents (PCL)
from 66–79 wt% (Table 1). In all cases, block polyester
formation was confirmed by 1H NMR spectra, SEC, 31P{1H}
NMR end-group titration, and DOSY NMR spectra (see
Figures S3–S5).[15]
To rationalize the self-assembly, calculations were con-
ducted on the copolymer chains using a semi-empirical
method PM7[12] with an implicit solvent model COSMO,[13]
assuming dielectric constants of 78.4 and 4.0 for the hydro-
philic and hydrophobic blocks, respectively. These calcula-
tions indicate the size of a single chain, and consequently how
Figure 1. a) Synthesis of PCL-b-PE. For detailed reaction conditions, see Tables S1–S3. b) Copolymer chain minimized and assembled into
a membrane which in turn encloses into a polymersome. c) TEM of a PCL38-b-PE7 polymersome dispersion: scale bar 500 nm. d) TEM of a single
polymersome made of PCL54-b-PE7 and e) the corresponding details for the membrane (scale bar 100 nm).
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it may pack in micelles or membranes (Table 1). Using the
results of the simulations and applying the general theory of
block polymer assembly,[15] the PCL chain length was
estimated as lPCL= 0.63NPCL
0.66 [where 0.63 (nm)= average
caprolactone monomer length]. Similarly, assuming a fully
stretched conformation for the hydrophilic block,[16] lPE=
0.8NPE [0.8 (nm)= average SA-ME3MO monomer length].
PCL-b-PE self-assembly was performed using a solvent-
switch method, whereby the copolymer is initially dissolved in
a good solvent for both blocks and then gradually exchanged
with water (see the Supporting Information for details).
Formulation characterizations, in terms of size and polydis-
persity, were assessed using dynamic light scattering (DLS;
see Figures S6 and S7).[17] The hydrodynamic diameters (Dh)
varied depending on the polyester building block composition
and overall molar mass (see Figure S6). The DLS measure-
ments suggest the formation of spherical structures whose
radius is considerably larger than a single chain length. This
feature implies that the copolymers assemble into membranes
that in turn form into spherical vesicles. Transmission electron
microscopy (TEM) was used to confirm the vesicular
structure (Figure 1c). All the samples appeared spherical,
with varied diameters, in agreement with DLS measurements,
and moreover support vesicle formation. TEMmeasurements
also enable estimation of the membrane thickness and values
increase with PCL block length (Table 1).[15] It is notable that
the vesicle size depends on a range of variables and is also
dependent upon the self-assembly preparation method. Here,
the polymersomes are prepared by the same method and by
controlling polymer composition and molar mass, and two
distinct polymersome populations are produced with consid-
erable differences in size.
Biodegradability studies were conducted using Pseudo-
monas cepacia lipase.[18] Experiments were monitored using
DLS (see the Supporting Information for details). Over the
first 30 minutes, a rapid decrease in the Dh from about 400 to
200 nmwas accompanied by an increase in polydispersity (see
Figure S9). As the mean count rate from DLS is proportional
to both the nanoparticle number and size, provided the
attenuator is fixed, its value was used to infer the
rate of enzymatic hydrolysis.[19] Over the first
30 minutes, the mean count rate decreased rapidly
from 151 to about 50 kcps (attenuator value= 6;
Figure 2). Whereas a control experiment without
lipase showed almost the same mean count rate
value over the equivalent period (see Figure S9).
These results suggest that the lipase catalyzes the
polyester hydrolysis, causing polymersome disas-
sembly and polymer dissolution. The polymer
degradation monitored by SEC reveals that from
2–4 hours, the overall molar mass decreased from
16.5–1.4 kgmol1 together with increased  (see
Figure S10 and Table S4). After 4 hours, polymer
signals are no longer detectable, indicating degra-
dation (see Table S4). The degradation products
were identified as succinic acid, 6-hydroxyhexanoic
acid, and the glycerol derivative with tri(ethylene
glycol) substituents using 1H NMR spectroscopy (see Fig-
ure S11).
The polymersomes drug loading/release profiles were
evaluated using either rhodamine B (RhB) or doxorubicin
hydrochloride (DOX·HCl) as water-soluble model drugs (see
Figures S12–S14).[20] In vitro drug release studies were
performed by dialysis against a phosphate buffer with or
without lipase, at 37 8C and pH 7.4 (see the Supporting
Information for details). The cumulative release profiles for
RhB- or DOX·HCl-loaded polymersomes exhibited broadly
similar behaviors (see Figures S13 and S14). In the absence of
lipase and after 20 hours, the cumulative drug release reached
about 70% compared to quantitative release from the free
drug control. When lipase was added, drug release was almost
complete within 1 hour (Figure 2). These release experiments






[f ] Dh [nm] (PDI)
[g] t [nm][h]
PCL38-OH 4.6 4.3 4.4 (1.15)
[e] – – –
PCL54-OH 5.7 6.2 6.4 (1.20)
[e] – – –
PCL38-b-PE7 9.1 6.6 11.0 (1.13) 10.9 537 (0.38) 6.41.2
PCL54-b-PE7 11.0 8.4 16.5 (1.18) 14.4 39813 (0.17) 8.61.4
PCL54-b-PE5 9.8 7.7 14.3 (1.20) 12.8 27713 (0.24) 8.71.6
Note: The data are acquired using purified polymers (see the Supporting
Information for details). [a] Polymerization conditions described in Tables S1–S3. PE
is used to represent P(SA-alt-ME3MO). [b] Theoretical molar mass, Samples #1–2:
Mn,theo= ([e-CL]  conversion  M[e-CL])/[n-hexanol] ; Samples #3–5= ([SA] 
conversion  M[SA+ME3MO])/([PCL-OH] + [e-CL]). [c] Calculated from
1H NMR
integrals (Table S3). [d] Determined by SEC, in THF, at 30 8C, calibrated using
narrow MW polystyrene standards. [e] Mn values for PCL corrected with a coefficient
(multiplied by 0.56).[11] [f ] Estimated size of a single polymer chain using the method
PM7[12] with an implicit solvent model COSMO[13] and assuming dielectric constants
of 78.4 and 4.0 for the hydrophilic and hydrophobic blocks, respectively.
[g] Polydispersity index determined by DLS in deionized water with polymer
0.25 mgmL1. [h] Hydrophobic membrane thickness measured by TEM.
Figure 2. Mean count rate (blue squares) versus time for polyester
polymersome solutions in the presence of lipase. Drug burst release
profiles for RhB (orange circles) and DOX·HCl (orange triangles)
loaded vesicles, representing the fits of the cumulative release profiles
for the drug-loaded polymersomes compared to the free drug release
across the dialysis membrane.[21] (see Figures S13 and S14 for
cumulative drug release profiles).
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are fully consistent with the observed polymer degradation
rates.
As mentioned, the PCL-b-PE is biodegraded into three
well-defined compounds, each of which is known to be
metabolizable.[22] To understand the polymersomes and
degradation products cytotoxicity, inflammatory, and
immune responses various in vitro cellular studies were
conducted. The materials were exposed to three cell lines,
including cancerous human oral carcinoma (FaDu), acute
leukemia monocyte-derived macrophages (MF), and healthy
primary dermal fibroblasts (HDF). As the cell-line selection
includes both professional (MF) and non-professional (FaDu
and HDF) phagocytes, the polymersomes cellular uptake
profile was evaluated using confocal image analyses (Fig-
ure 3a). They were all successfully internalized by all cells
within 24 hours, with maximum uptake occurring over
48 hours (Figures 3b; see Figure S15). Image quantification
analyses showed that while HDFand FaDu cells share similar
uptake profiles, the MF showed enhanced uptake after
48 hours. Cell viability was evaluated using a metabolic assay
(see the Supporting Information for details). FaDu cells were
unaffected by all materials regardless of either concentration
or incubation time (see Figure S16). MF treated with
polymersomes showed significantly decreased viability (ca.
50% at 28 mgmL1), but were unaffected by the degradation
products even after 48 hours (see Figure S16). This decreased
viability may be correlated with the enhanced macrophage
uptake. Polymersomes should be internalized by both endo-
or phagocytosis (the latter being a special trait of MF),[23]
resulting in higher uptake. It is also known that increased
succinic acid concentration can reduce the mitochondrial
membrane potential, which in turn boosts production of
reactive oxygen species (ROS).[24] Thus, the increased meta-
bolic activity could be related to such ROS (see Figure S16).
In contrast, polymersome treatment increased HDF mito-
chondrial activity (see Figure S16) and hence cell prolifer-
ation as confirmed using a total cell counting assay (see
Figure S17).
To understand the molecular bases for the differentiated
cellular responses, gene expression profiles were evaluated by
quantitative polymerase chain reactions (qPCR). The
selected genes include cell cycle regulators p21 and p53,
intracellular misfolded protein sensors ATF4 and ATF6, and
general cell-stress sensor CYP1B1. For HDF, after 24 hours of
treatment with 398 nm polymersomes, an up-regulation of an
ATF4 sensor was induced, indicating possible formation of
intracellular misfolded proteins (Figure 3c). Conversely, in
MF such an effect was observed for 53 nm polymersomes
(Figure 3d). Both qPCR analyses revealed that polymer-
somes induced a significant down-regulation of p21 and p53,
and could explain the improved HDF proliferation activity as
these genes promote cell growth.[25] Likewise, down-regula-
tion of CYP1B1 is a strong indicator of general cellular stress.
Moreover, MF treated with either 398 nm polymersomes
or degradation products showed down-expression of ATF4,
ATF6, p21, and p53 (Figure 3d). Thus, in line with the
metabolic activity studies, suggesting induced cell apoptosis
(see Figure S16). To understand whether increased cell stress
could be related to an inflammation process, the nuclear
translocation of the nuclear factor kappa B (Nf-kB) was
evaluated.[26] Nf-kB is an effector protein that transfers from
the cytosol to the nucleus at the start of inflammation.[26]
Upon binding to conserved DNA regions the transcription of
inflammation-related genes, like cytokines and chemokines,
occurs.[26] No enhanced Nf-kB nuclear translocation was
observed for any of the materials even after 48 hours (see
Figure S18). This observation indicates that the decreased
MF viability is most likely a result of succinic acid promoted
production of ROS, resulting from intrinsic cell phagocytosis.
Taken together, these in vitro cellular results support two
main hypotheses: the PCL-b-PE polymersomes induce the
hyper-proliferation of fibroblasts but reduce viability of
macrophages, and both are important outcomes in most
healing processes. Further, both effects correlate with supra-
molecular structure and size.
In summary, new amphiphilic and degradable block
polyesters were prepared in high yield using controlled
polymerizations, which allow easy control of composition.
They degrade to metabolites including succinic acid, 6-
hydroxyhexanoic acid, and a derivative of glycerol. Degrad-
able polymer nanostructures are important in current and
future drug delivery, yet their bioactivity and that of
degradation products remains rather poorly understood.
This work demonstrates the potential to exploit polymers
and degradation products to modulate cell behavior, for
example, stimulating the proliferation of dermal fibroblasts.
These nascent materials designed for metabolic activity
should be optimized in future for selective drug delivery,
cell-specific wound healing, or targeted tissue engineering.
This work highlights, for the first time, the scope for new
alternating polyesters both as polymer hydrophiles and for
future medical applications. Given the broad range of
commercially available and functionalized epoxides/anhy-
Figure 3. a) Confocal images of FaDu, MF, and HDF incubated with
RhB-polymersomes (398 nm, in green) for 24 and 48 h. The cell nuclei
were stained with DAPI in blue and red CellMaskTM was used for cell
membrane staining. b) Quantification of uptake of both polymersomes
in HDF, FaDu, and MF over 48 h (n=3 independent experiments).
c,d) The qPCR analyses for quantifying gene expression in HDF and
MF, respectively. All experiments were carried out as three independ-
ent replicates, followed by t-test statistical analyses (*p<0.05).
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drides and their high thermodynamic polymerizability, many
other block polymers should be accessible using the methods
demonstrated here. It is also straightforward to control the
chain end group chemistry, alternating side-chain substitu-
ents, degree of hydrophilicity, and crosslinking, and all
provide future opportunities for fine-tuning desired bioactiv-
ities.
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Metabolically Active, Fully Hydrolysable
Polymersomes
Class act : The synthesis and aqueous
self-assembly of a new class of amphi-
philic aliphatic polyesters are presented.
They self-assemble into biodegradable
polymersomes capable of entering cells.
Their degradation products are bioactive,
giving rise to differentiated cellular
responses inducing stromal cell prolifer-
ation and macrophage apoptosis. Both
effects emerge only when the copolymers
enter cells as polymersomes.
Angewandte
ChemieCommunications
7Angew. Chem. Int. Ed. 2019, 58, 1 – 7  2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
These are not the final page numbers! 
